-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Reiterates Buy on Journey Medical, Lowers Price Target to $13

Benzinga·11/13/2026 14:26:03
Diffusion vocale
B. Riley Securities analyst Mayank Mamtani reiterates Journey Medical (NASDAQ:DERM) with a Buy and lowers the price target from $15 to $13.